VTRS240621P20000
- 10.80
- 0.000.00%
Viatris Newsroom
Express News | Viatris Statement Regarding European Commission’s Approval for Proposed Divestiture of Its Over-the-Counter Business to Cooper Consumer Health
EU: Meeting Conditions Would Address Competition Concerns of Merger
EU: Meeting Conditions Would Address Competition Concerns of Merger
Express News | EU Approval Conditional on Cooper Selling Rights and Interests in Infant Laxative Medicine and Earwax Removal Product
Express News | Cooper Consumer Health Gains EU Antitrust Approval to Buy Viatris' European Over-the-Counter Drug Business
Viatris Named to TIME's World's Most Sustainable Companies 2024 List
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to the inaugural edition of TIME's World's Most...
Goldman's Top 50 High Sharpe Ratio Stocks
Goldman Sachs analysts rebalanced their “high Sharpe Ratio” basket, which identifies 50 S&P 500 (SP500) stocks with the highest prospective risk-adjusted returns compared to their sector peers.
Viatris(VTRS.US) Director Sells US$3.59 Million in Common Stock
$Viatris(VTRS.US)$ Director Malik Rajiv sold 349.96K shares of common stock on Jun 13, 14, 2024 at an average price of $10.2612 for a total value of $3.59 million.Source: Announcement What is statemen
Form 144 | Viatris(VTRS.US) Insider Proposes to Sell 3.65 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 13, $Viatris(VTRS.US)$ Insider Malik Rajiv intends to sell 350K shares of its common stock on Jun 13, with a total market value of approximately $3.65 million. Source: A
Viatris Inc. (VTRS) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
Viatris Inc. (VTRS) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024
Viatris Inc. (NASDAQ: VTRS) will report its second quarter 2024 financial results on Thursday, August 8, 2024, before the open of the U.S. financial...
Viatris Inc. (VTRS) Presents at Jefferies 2024 Global Healthcare Conference (Transcript)
Viatris Inc. (VTRS) Presents at Jefferies 2024 Global Healthcare Conference (Transcript)
Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Express News | Viatris Statement on the Close of the Active Pharmaceutical Ingredients Business Divestiture
Express News | Viatris: Board Increased Number of Directors on Board From 11 to 12 & Appointed Rogério Vivaldi Coelho as Independent Member of Board
Express News | Viatris Appoints Rogerio Vivaldi Coelho, M.d., to Board of Directors
Viatris to Participate in the Jeffries Global Healthcare Conference
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the Jeffries Global Healthcare Conference...
Insider Sale: Chief Legal Officer Brian Roman Sells 89,419 Shares of Viatris Inc (VTRS)
Viatris(VTRS.US) Officer Sells US$928.43K in Common Stock
$Viatris(VTRS.US)$ Officer Roman Brian sold 89,419 shares of common stock on May 28, 2024 at an average price of $10.3829 for a total value of $928.43K.Source: Announcement What is statement of change
Form 144 | Viatris(VTRS.US) Officer Proposes to Sell 928.43K in Common Stocks
SEC FILLINGS DISCLOSED/ May 28, $Viatris(VTRS.US)$ Officer Roman Brian intends to sell 89,419 shares of its common stock on May 28, with a total market value of approximately $928.43K. Source: Anno
Peering Into Viatris's Recent Short Interest
Viatris's (NYSE:VTRS) short percent of float has risen 9.41% since its last report. The company recently reported that it has 44.95 million shares sold short, which is 4.3% of all regular shares that